¥337 Million Spent on Research and Development
First written in FY2018-Q3. . Latest entry: FY2026.
49 other companies' latest entry also says "Other".
- FY2026Update to Full-Year R&D ResultsAnnual report
「Total research and development expenses for the consolidated fiscal year were ¥509,543 thousand. The company filed 5 patent applications in Japan and had 33 research personnel.」
Research and development expenses were ¥509,543 thousand, with 5 domestic patent applications and 33 research personnel. - FY2026-H1Updated interim-period R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the interim consolidated accounting period was ¥250 million.」
Research and development activity spending during the interim consolidated accounting period was ¥250 million. The company stated that there had been no material change in the status of its research and development activities. - FY2025Update to Full-Year R&D ResultsAnnual report
「Total research and development expenses for the consolidated fiscal year were ¥434,374 thousand. The company filed 5 patent applications in Japan and had 32 research personnel.」
Full-year research and development expenses were ¥434,374 thousand, with 5 domestic patent applications and 32 research personnel. - FY2025-H1Updated interim-period R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the interim consolidated accounting period was ¥208 million.」
Research and development activity spending during the interim consolidated accounting period was ¥208 million. The company stated that there had been no material change in the status of its research and development activities. - FY2024Update to Full-Year R&D ResultsAnnual report
「Total research and development expenses for the consolidated fiscal year were ¥389,758 thousand. The company filed 2 patent applications in Japan and had 31 research personnel.」
The filing reported full-year research and development expenses of ¥389,758 thousand, 2 domestic patent applications, and 31 research personnel. - FY2024-Q3Update to R&D expenses for the first 3 quartersAnnual report
「The group-wide amount spent on research and development activities during the third-quarter cumulative consolidated accounting period was ¥293 million.」
Research and development activity spending during the third-quarter cumulative consolidated accounting period was ¥293 million. The company stated that there had been no material change in the status of its research and development activities. - FY2024-Q2Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the second-quarter cumulative consolidated accounting period was ¥182 million.」
Research and development activity spending during the second-quarter cumulative period was ¥182 million. The company stated that there had been no material change in the status of its research and development activities. - FY2024-Q1Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the first-quarter cumulative consolidated accounting period was ¥91 million.」
Research and development activity spending during the first-quarter cumulative period was ¥91 million. The company stated that there had been no material change in the status of its research and development activities. - FY2023Update to Full-Year R&D ResultsAnnual report
「Total research and development expenses for the consolidated fiscal year were ¥395,237 thousand. The company filed 4 patent applications in Japan and had 31 research personnel.」
The filing reported full-year research and development expenses of ¥395,237 thousand, 4 domestic patent applications, and 31 research personnel. - FY2023-Q3Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the third-quarter cumulative consolidated accounting period was ¥297 million.」
Research and development activity spending during the third-quarter cumulative period was ¥297 million. The company stated that there had been no material change in the status of its research and development activities. - FY2023-Q2Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the second-quarter cumulative consolidated accounting period was ¥204 million.」
Research and development activity spending during the second-quarter cumulative period was ¥204 million. The company stated that there had been no material change in the status of its research and development activities. - FY2023-Q1Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the first-quarter cumulative consolidated accounting period was ¥95 million.」
Research and development activity spending during the first-quarter cumulative period was ¥95 million. The company stated that there had been no material change in the status of its research and development activities. - FY2022Update to Full-Year R&D ResultsAnnual report
「Total research and development expenses for the consolidated fiscal year were ¥413,872 thousand. The company filed 8 patent applications in Japan, registered 3 patents in Japan, and had 30 research personnel.」
The filing reported full-year research and development expenses of ¥413,872 thousand, 8 domestic patent applications, 3 domestic patent registrations, and 30 research personnel. - FY2022-Q3Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the third-quarter cumulative consolidated accounting period was ¥316 million.」
Research and development activity spending during the third-quarter cumulative period was ¥316 million. The company stated that there had been no material change in the status of its research and development activities. - FY2022-Q2Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the second-quarter cumulative consolidated accounting period was ¥210 million.」
Research and development activity spending during the second-quarter cumulative period was ¥210 million. The company stated that there had been no material change in the status of its research and development activities. - FY2022-Q1Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the first-quarter cumulative consolidated accounting period was ¥103 million.」
Research and development activity spending during the first-quarter cumulative consolidated accounting period was ¥103 million. The company stated that there had been no material change in the status of its research and development activities. - FY2021Full-Year R&D Expense UpdateAnnual report
「Total research and development expenses for the consolidated fiscal year were ¥470,285 thousand. The company filed 6 patent applications in Japan, registered 2 patents in Japan, and had 32 research personnel.」
The filing reported full-year research and development expenses of ¥470,285 thousand, 6 domestic patent applications, 2 domestic patent registrations, and 32 research personnel. - FY2021-Q3Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the third-quarter cumulative consolidated accounting period was ¥354 million.」
Research and development activity spending during the third-quarter cumulative consolidated accounting period was ¥354 million. The company stated that there had been no material change in the status of its research and development activities. - FY2021-Q2Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the second-quarter cumulative consolidated accounting period was ¥230 million.」
Research and development activity spending during the second-quarter cumulative period was ¥230 million, down from ¥251 million in the same period of the previous year. The company stated that there had been no material change in the status of its research and development activities. - FY2021-Q1Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the first-quarter cumulative consolidated accounting period was ¥112 million.」
Research and development activity spending during the first-quarter cumulative consolidated accounting period was ¥112 million, down from ¥129 million in the same period of the previous year. The company stated that there had been no material change in the status of its research and development activities. - FY2020-Q3Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the third-quarter cumulative consolidated accounting period was ¥375 million.」
Research and development activity spending during the third-quarter cumulative consolidated accounting period was ¥375 million. - FY2020-Q2Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the second-quarter cumulative consolidated accounting period was ¥246 million.」
Research and development activity spending during the second-quarter cumulative consolidated accounting period was ¥246 million, a slight decrease from ¥251 million in the same period of the previous year. - FY2020-Q1Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the first-quarter cumulative consolidated accounting period was ¥127 million.」
Research and development activity spending during the first-quarter cumulative consolidated accounting period was ¥127 million, a slight decrease from ¥129 million in the first quarter of the previous year. - FY2019Full-Year R&D Expense UpdateAnnual report
「Total research and development expenses for the consolidated fiscal year were ¥505,160 thousand.」
Full-year research and development expenses were ¥505,160 thousand, up from ¥435,639 thousand in the previous fiscal year. - FY2019-Q3Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the third-quarter cumulative consolidated accounting period was ¥375 million.」
Research and development activity spending during the third-quarter cumulative consolidated accounting period was ¥375 million. - FY2019-Q2Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the second-quarter cumulative consolidated accounting period was ¥251 million.」
Research and development activity spending during the second-quarter cumulative consolidated accounting period was ¥251 million. - FY2019-Q1Update to quarterly R&D expensesAnnual report
「The group-wide amount spent on research and development activities during the first-quarter cumulative consolidated accounting period was ¥129 million.」
Research and development activity spending during the first-quarter cumulative consolidated accounting period was ¥129 million. - FY2018Full-Year R&D Expense UpdateAnnual report
「Total research and development expenses for the consolidated fiscal year were ¥435,639 thousand.」
Full-year research and development expenses were ¥435,639 thousand. - FY2018-Q3First statedAnnual report
「The group-wide amount spent on research and development activities during the third-quarter cumulative consolidated accounting period was ¥337 million.」
The group-wide amount spent on research and development activities during the third-quarter cumulative consolidated accounting period was reported as ¥337 million.